These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26225260)

  • 21. Linking physiology to toxicity using DILIsym®, a mechanistic mathematical model of drug-induced liver injury.
    Shoda LK; Woodhead JL; Siler SQ; Watkins PB; Howell BA
    Biopharm Drug Dispos; 2014 Jan; 35(1):33-49. PubMed ID: 24214486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use.
    Jonsson F; Ou Y; Claret L; Siegel D; Jagannath S; Vij R; Badros A; Aggarwal S; Bruno R
    CPT Pharmacometrics Syst Pharmacol; 2015 Dec; 4(12):711-9. PubMed ID: 26904385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 19S cap puzzle: a new jigsaw piece.
    Huber EM; Groll M
    Structure; 2012 Mar; 20(3):387-8. PubMed ID: 22404996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical modeling of drug delivery.
    Siepmann J; Siepmann F
    Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A versatile mathematical work-flow to explore how Cancer Stem Cell fate influences tumor progression.
    Fornari C; Balbo G; Halawani SM; Ba-Rukab O; Ahmad AR; Calogero RA; Cordero F; Beccuti M
    BMC Syst Biol; 2015; 9 Suppl 3(Suppl 3):S1. PubMed ID: 26050594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle.
    Ren X
    Cancer Biol Med; 2019 May; 16(2):205-210. PubMed ID: 31516742
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.
    Sy SK; Zhuang L; Derendorf H
    Expert Opin Drug Metab Toxicol; 2016; 12(1):93-114. PubMed ID: 26652832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling techniques for inhaled particle deposition: the state of the art.
    Hofmann W
    J Aerosol Med; 1996; 9(3):369-88. PubMed ID: 10163662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
    Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
    Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autonomic nerves in cancer: a missing piece of the jigsaw puzzle].
    Magnon C
    Med Sci (Paris); 2013; 29(8-9):699-701. PubMed ID: 24005623
    [No Abstract]   [Full Text] [Related]  

  • 35. Emotions and affects: the missing piece of the jigsaw puzzle of understanding risk attitudes in medical decision-making.
    Subramani S
    J Med Ethics; 2023 Nov; 49(11):746-747. PubMed ID: 37586829
    [No Abstract]   [Full Text] [Related]  

  • 36. Time evolution of epidemic disease on finite and infinite networks.
    Noël PA; Davoudi B; Brunham RC; Dubé LJ; Pourbohloul B
    Phys Rev E Stat Nonlin Soft Matter Phys; 2009 Feb; 79(2 Pt 2):026101. PubMed ID: 19391800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: where does the chemotherapy piece fit?
    Rischin D; Peters LJ
    J Clin Oncol; 2002 Apr; 20(8):1968-70. PubMed ID: 11956253
    [No Abstract]   [Full Text] [Related]  

  • 38. Preshock phase singularity and defibrillation outcome: another piece to solve the jigsaw puzzle?
    Chattipakorn N
    Heart Rhythm; 2007 Jul; 4(7):935-7. PubMed ID: 17599681
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.
    Ribba B; Holford NH; Magni P; Trocóniz I; Gueorguieva I; Girard P; Sarr C; Elishmereni M; Kloft C; Friberg LE
    CPT Pharmacometrics Syst Pharmacol; 2014 May; 3(5):e113. PubMed ID: 24806032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology and aging: the jigsaw puzzle of design, development and distribution.
    Lee C
    Nat Aging; 2022 Dec; 2(12):1077-1079. PubMed ID: 37118534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.